"10.1371_journal.pone.0149077","plos one","2016-02-11T00:00:00Z","Masanori Tsujimoto; Gen Kuroyanagi; Rie Matsushima-Nishiwaki; Yuko Kito; Yukiko Enomoto; Hiroki Iida; Shinji Ogura; Takanobu Otsuka; Haruhiko Tokuda; Osamu Kozawa; Toru Iwama","Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan; Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan; Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japan; Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu, Japan; Department of Clinical Laboratory, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan","Conceived and designed the experiments: MT OK TI. Performed the experiments: MT GK YK YE HI. Analyzed the data: MT RM-N OK TI. Contributed reagents/materials/analysis tools: MT RM-N YK OK. Wrote the paper: MT HI SO TO HT OK TI.","The authors have the following interests. This study was supported in part by research funding from Bayer Yakuhin, Ltd. Rivaroxaban and edoxaban were kindly provided by Bayer Vital GmbH (Leverkusen, Germany) and Daiichi Sankyo Co., Ltd. (Tokyo, Japan), respectively. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Masanori Tsujimoto","MT",11,TRUE,3,5,4,7,TRUE,TRUE,FALSE,0,NA,FALSE
